Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2009

Jul 28, 2009

30718_dirs_2009-07-28_4c21a40b-6c42-40fd-b1ee-9d241967c5de.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2009-07-24

Reporting Person: VERONNEAU MARCEL (VP-Hematology Operations)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-07-24 Employee stock option $62.46 A 494 Acquired 2016-07-23 Common Stock (494) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 31299 Direct
Common Stock 6616 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee stock option $79.41 2015-07-24 Common Stock (385) 385 Direct
Employee stock option $56.83 2014-07-26 Common Stock (510) 510 Direct
Employee stock option $49.43 2013-07-27 Common Stock (567) 567 Direct
Employee stock option $51.6 2012-08-17 Common Stock (475) 475 Direct
Employee stock option $37.011 2010-12-30 Common Stock (15000) 15000 Direct
Employee stock option $40.47 2011-07-08 Common Stock (505) 505 Direct
Employee stock option $33.85 2010-08-13 Common Stock (670) 670 Direct